SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-21-102234
Filing Date
2021-03-31
Accepted
2021-03-31 16:01:55
Documents
3
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d139974d10ka.htm 10-K/A 304030
2 EX-31.3 d139974dex313.htm EX-31.3 3307
3 EX-31.4 d139974dex314.htm EX-31.4 2983
  Complete submission text file 0001193125-21-102234.txt   311455
Mailing Address 134 COOLIDGE AVENUE 2ND FLOOR WATERTOWN MA 02472
Business Address 134 COOLIDGE AVENUE 2ND FLOOR WATERTOWN MA 02472 617-393-5925
Pandion Therapeutics, Inc. (Filer) CIK: 0001807901 (see all company filings)

IRS No.: 833015614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39381 | Film No.: 21793166
SIC: 2834 Pharmaceutical Preparations